Document is current
Any future updates will be listed below
-
Authors
Levillain, Hugo https://orcid.org/0000-0003-3909-625X
Moës, Anne Royer
Gameiro-Paris, Cristiana
Abrunhosa, Antero https://orcid.org/0000-0002-4145-854X
Deakin, Tom
Gebhart, Geraldine https://orcid.org/0000-0001-8853-0783
Herth, Matthias M. https://orcid.org/0000-0002-7788-513X
Gestin, Jean-François https://orcid.org/0000-0002-2804-473X
Haddad, Ferid https://orcid.org/0000-0001-6971-5969
Jensen, Andreas Ingemann https://orcid.org/0000-0003-4302-2982
Bue, Rebecca Lo
Mikolajczak, Renata https://orcid.org/0000-0002-6882-751X
Otamendi, Adrian https://orcid.org/0000-0001-5954-0915
Staunton-Mann, Katie
Tabury, Kevin https://orcid.org/0000-0002-8004-3718
Flamen, Patrick https://orcid.org/0000-0003-2193-6599
,
Battisti, Umberto M.
Bourdeau, Cécile
Chérel, Michel
Damas, Liliana
Delbart, Wendy
Ferrer, Ludovic
Fouinneteau, Romain
Guérard, François
Garcia, Rocío
Geets, Jean-Michel
Harray, Jérôme
Humpert, Swen
Jensen, Holger
Lacombe, Marie
Pruszyński, Marek
Neumaier, Bernhard
Primac, Irina
Seimbille, Yann
-
Funding
Funding for this research was provided by:
Innovative Health Initiative (101173001)
- License Information
-
More Information
Article History
Received: 24 February 2026
Accepted: 19 May 2026
First Online: 29 May 2026
Declarations
:
: NA.
: NA.
: NA.
: All authors are members of the Accelerate.EU consortium, funded through the Innovative Health Initiative Joint Undertaking (IHI JU), a public–private partnership supported by the European Union and industry associations (COCIR, EFPIA, EuropaBio, MedTech Europe, Vaccines Europe). Industrial partners IBA, Tetrakit and LabLogic provide in‑kind contributions to the project. The authors note that Accelerate.EU operates within a pre‑competitive, non‑commercial research framework, and they receive no personal financial benefit from industry participation. These affiliations did not influence the content of this editorial. No additional competing interests are declared.
